newsfilter
← Latest News
PR Newswire·

VolitionRx Announces Pricing of $4.6 Million Public Offering

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the pricing of its previously announced...